Related Experiment Video
Updated: Jan 10, 2026

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
Published on: June 14, 2016
The Role of MUC1 in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): The Correlation with Disease Severity
Rossana Giancaspro1, Giuseppe Stefano Netti2, Federica De Luca2
1Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Via Luigi Pinto 1, 71122 Foggia, Italy.
Abstract:
Background: Mucins, particularly MUC1, are involved in the pathogenesis of chronic respiratory diseases. In chronic rhinosinusitis with nasal polyposis (CRSwNP), altered mucin expression may contribute to chronic inflammation and tissue remodeling. However, the specific role of MUC1 in CRSwNP and its correlation with clinical severity and inflammatory pathway remains unclear. Objective: We aimed to evaluate the MUC-1 expression in nasal polyps of patients with CRSwNP and to assess the correlation of MUC-1 expression and disease severity, according to Clinical-Cytological Grading (CCG). Methods: Eighteen consecutive patients with CRSwNP who underwent endoscopic sinus surgery (ESS) were enrolled. A double-label immunofluorescence was performed to evaluate the expression of MUC-1, CD15 and Tryptase and their eventual co-localization on histological samples. Double-positive MUC-1+CD15+ and MUC-1+Tryptase+ inflammatory cells were counted by confocal microscopy. Results: MUC1 was expressed in all samples, with a significantly increasing expression in relation to CCG (p < 0.001). A significant co-localization between MUC1 and CD15+ eosinophils was observed, with a progressive increase in the number of double-positive cells from low to high CCG (p < 0.001). On the contrary, the co-localization between MUC1 and Tryptase+ mast cells was not significant, although both markers showed a higher expression in cases with high CCG (p < 0.001). Conclusions: A strong correlation between CRSwNP severity and MUC-1 expression, mainly colocalized with infiltrating eosinophils, was shown. This offers a promising perspective for the use of MUC-1 as a biomarker of CRSwNP.
Insights
Mucin 1 (MUC1) expression correlates with chronic rhinosinusitis with nasal polyposis (CRSwNP) severity, particularly with eosinophils. This finding suggests MUC1 may serve as a valuable biomarker for CRSwNP.
Area of Science:
- Immunohistochemistry and molecular pathology of respiratory diseases.
- Cellular and molecular mechanisms of chronic inflammation in CRSwNP.
Background:
- Mucins, especially MUC1, play a role in chronic respiratory disease pathogenesis.
- Altered mucin expression in chronic rhinosinusitis with nasal polyposis (CRSwNP) may drive inflammation and tissue remodeling.
- The specific role of MUC1 in CRSwNP and its link to disease severity remains unclear.
Purpose of the Study:
- To evaluate MUC-1 expression in nasal polyps from CRSwNP patients.
- To assess the correlation between MUC-1 expression and CRSwNP disease severity using the Clinical-Cytological Grading (CCG) system.
Main Methods:
- Eighteen CRSwNP patients undergoing endoscopic sinus surgery (ESS) were studied.
- Double-label immunofluorescence was used to detect MUC-1, CD15 (eosinophils), and Tryptase (mast cells).
- Confocal microscopy quantified co-localization of MUC-1 with inflammatory cells (MUC-1+CD15+ and MUC-1+Tryptase+).
Main Results:
- MUC1 was universally expressed in nasal polyps, with significantly increased levels correlating with higher CCG scores (p < 0.001).
- Significant co-localization of MUC1 with CD15+ eosinophils was observed, increasing with disease severity (p < 0.001).
- MUC1 co-localization with Tryptase+ mast cells was not significant, though both markers increased in severe CRSwNP (p < 0.001).
Conclusions:
- A strong correlation exists between CRSwNP severity and MUC-1 expression, predominantly co-localized with eosinophils.
- MUC-1 shows potential as a reliable biomarker for assessing CRSwNP severity.
- Further research into MUC-1's role could inform targeted therapeutic strategies for CRSwNP.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Cystic Fibrosis: Management
Sinus disease and chronic...
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

